Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

galanin-NPY chimeric peptide M88

Known as: neuropeptide Y(25-36)amide, galanin(1-12)-Ala-, galanin(1-12)-Ala-neuropeptide Y(25-36)amide, M88 peptide 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (3)

GalaninPeptide Fragmentsneuropeptide Y
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor.
The widely expressed dipeptidyl peptidase-4 enzyme rapidly cleaves the gut hormone glucagon-like peptide-1 [GLP-1(7-36)amide] at… 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2007
Highly Cited
2007
GLP-1 Receptor Expression in Human Tumors and Human Normal Tissues: Potential for In Vivo Targeting
Peptide hormone receptors overexpressed in human tumors, such as somatostatin receptors, can be used for in vivo targeting for… 
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Highly Cited
2003
Highly Cited
2003
Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects
Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are both incretin hormones regulating… 
Highly Cited
2001
Highly Cited
2001
Effect of metformin on glucagon-like peptide 1 (GLP-1) and leptin levels in obese nondiabetic subjects.
OBJECTIVE To evaluate the effects of metformin on glucagon-like peptide 1 (GLP-1) and leptin levels. RESEARCH DESIGN AND… 
  • figure 1
  • figure 2
Highly Cited
1999
Highly Cited
1999
Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine.
The insulinotropic hormone glucagon-like peptide-1 (GLP-1) is stored in the intestinal L cell in an active form, GLP-1-(7-36… 
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 6
Highly Cited
1998
Highly Cited
1998
Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans.
The gastrointestinal hormone, glucagon-like peptide-1(7-36)amide (GLP-1) is released after a meal. The potency of synthetic GLP-1… 
  • table I
  • figure 1
  • figure 2
  • table II
  • table III
Highly Cited
1996
Highly Cited
1996
Gastric emptying and release of incretin hormones after glucose ingestion in humans.
This study investigated in eight healthy male volunteers (a) the gastric emptying pattern of 50 and 100 grams of glucose; (b) its… 
  • table I
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
1995
Highly Cited
1995
Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo.
The metabolism of glucagon-like peptide-1 (GLP-1) has not been studied in detail, but it is known to be rapidly cleared from the… 
Highly Cited
1993
Highly Cited
1993
Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum.
Peptides of the glucagon/vasoactive-intestinal-peptide (VIP) peptide family share a considerable sequence similarity at their N… 
Highly Cited
1993
Highly Cited
1993
Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns.
The acute effects of different macronutrients on the secretion of glucagon-like peptide-1(7-36)amide (GLP-1(7-36)amide) and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE